|
|
Article: Dr. Reddy's Laboratories.(RX/GENERIC DRUGS--Profiles)(Dr. Reddy's Laboratories Ltd.)(Company overview)
- Article from:
- Chain Drug Review
- Article date:
- September 29, 2008
CopyrightCOPYRIGHT 2008 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BRIDGEWATER, N.J. -- The mission of Dr. Reddy's Laboratories is twofold: to provide patients access to high-quality generic medicines at affordable prices, and to develop new treatments to satisfy unmet medical needs while improving existing therapies.
Dr. Reddy's generics operations started in 2001, marketing its products primarily in the United States, Canada and the European Union. In North America the company currently markets 34 products in more than 147 presentations under the Dr. Reddy's label.
The company has an aggressive generics pipeline. In the past year Dr. Reddy's has launched such prescription generic products as Zolpidem, Terbinafine, ...